Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-96-000308
Filing Date
1996-03-29
Accepted
1996-03-29 00:00:00
Documents
8
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 1995 10-K 189671
2 AMENDMENT TO LOAN AGREEMENT EX-4.1 15002
3 STATEMENT OF COMPUTATION OF PER SHARE EARNINGS EX-11.1 2685
4 SUBSIDIARIES OF THE COMPANY EX-21.1 705
5 CONSENT OF PRICE WATERHOUSE LLP EX-23.1 572
6 CONSENT OF DELOITTE & TOUCHE LLP EX-23.2 624
7 FINANCIAL DATA SCHEDULE EX-27.1 2075
8 CONSOLIDATED FINANCIAL STATEMENTS OF SOMERSET EX-99.1 32678
  Complete submission text file 0000892569-96-000308.txt   246250
Mailing Address 311 BONNIE CIRCLE CORONA CA 91720
Business Address 311 BONNIE CIRCLE CORONA CA 91720 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20045 | Film No.: 96540572
SIC: 2833 Medicinal Chemicals & Botanical Products